ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Brain Research
Volume 1085, Issue 1, 26 April 2006, Pages 49-56
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (374 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.brainres.2006.02.033    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2006 Elsevier B.V. All rights reserved.

Research Report

Possible involvement of 5α-reduced neurosteroids in adrenergic and serotonergic stimulation of GFAP gene expression in rat C6 glioma cells

Kyoji Moritaa, Corresponding Author Contact Information, E-mail The Corresponding Author, Hideki Arimochib, Hiroyuki Itoha and Song Herc, 1

aDepartment of Pharmacology, Tokushima University School of Medicine, 3-18-15 Kuramoto, Tokushima 770-8503, Japan bDepartment of Molecular Bacteriology, Tokushima University School of Medicine, Kuramoto, Tokushima 770-8503, Japan cDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305-5485, USA

Accepted 7 February 2006. 
Available online 3 April 2006.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Influence of adrenergic and serotonergic stimulation on glial fibrillary acidic protein (GFAP) gene expression in rat C6 glioma cells was first examined as an in vitro model experiment for investigating the neuronal regulation of glial cell differentiation. Stimulation of these cells with isoproterenol and serotonin elevated GFAP mRNA levels followed by an increase in its protein contents, thus suggesting that both adrenergic and serotonergic stimulation might induce the differentiation of the glioma cells. In addition, progesterone and its 5α-reduced metabolite dihydroprogesterone also elevated GFAP mRNA levels in rat C6 glioma cells, consistent with their stimulatory actions on GFAP gene expression observed in rat astrocytes (Melcangi, R.C., Riva, M.A., Fumagalli, F., Magnaghi, V., Racagni, G., Martini, L., 1996. Effect of progesterone, testosterone and their 5α-reduced metabolites on GFAP gene expression in type 1 astrocytes, Brain Res. 711, 10–15). Further studies showed that the elevation of GFAP mRNA levels induced by isoproterenol and serotonin as well as progesterone was abolished by pretreatment of the glioma cells with finasteride, an inhibitor of 5α-reduced steroid production. Moreover, the stimulatory actions of isoproterenol and serotonin on GFAP gene expression were inhibited by pretreatment with a GABAA receptor antagonist bicuculline and a progesterone receptor antagonist RU486. These findings suggest that both adrenergic and serotonergic stimulation may indirectly activate GFAP gene expression probably through the production of 5α-reduced steroid metabolites in rat C6 glioma cells, proposing the possibility that 5α-reduced neurosteroids may play a potential role in the neuronal regulation of glial cell differentiation.

Keywords: Adrenergic and serotonergic stimulation; GFAP gene expression; Glial cell differentiation; 5α-reduced neurosteroid

Abbreviations: GFAP, glial fibrillary acidic protein; 5α-R, steroid 5α-reductase type 1; Egr-1, early growth response factor-1; DMEM, Dulbecco's modified Eagle's medium; RT-PCR, reverse transcription-polymerase chain reaction; GAPDH, glyceraldehyde 3-phosphate dehydrogenase

Article Outline

1. Introduction
2. Results
2.1. One-step RT-PCR analysis of GFAP mRNA levels
2.2. Effects of progesterone and dihydroprogesterone on GFAP mRNA levels
2.3. Influence of adrenergic and serotonergic stimulation on GFAP gene expression
2.4. Effect of finasteride on adrenergic and serotonergic stimulation of GFAP gene expression
2.5. Effects of bicuculline and RU486 on adrenergic and serotonergic stimulation of GFAP gene expression
3. Discussion
4. Experimental procedures
4.1. Materials
4.2. Cell culture and drug treatment
4.3. Semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) analysis
4.4. Immunoblotting analysis
4.5. Data analysis
Acknowledgements
References







Brain Research
Volume 1085, Issue 1, 26 April 2006, Pages 49-56
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.